Mefloquine Prophylaxis Results and Evaluation of adVerse Effects iN Peacekeepers Travelling to South Sudan: Mefloquine PREVENT–SS Study
This retrospective study of Indian UN peacekeepers in South Sudan demonstrates that consistent adherence to Mefloquine prophylaxis significantly reduces malaria risk, though fear of and experience with neuropsychiatric adverse effects remain the primary barriers to compliance.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Malaria is a relentless disease in many parts of the world, caused by a parasite that enters the body through the bite of an infected mosquito. In regions where the disease is always present, such as South Sudan, the risk is constant, and the local healthcare systems are often overwhelmed by the sheer number of cases. For people traveling from areas where malaria does not exist, the threat is even more severe because their bodies have no natural defense against it. To stay safe, travelers and military personnel deployed to these zones rely on chemoprophylaxis, which is simply the practice of taking medicine regularly to prevent the infection before it can take hold. One of the most common medicines used for long-term protection is mefloquine, a drug taken once a week. While it is highly effective at stopping the parasite from multiplying in the blood, it is also known to cause side effects that can be unsettling, particularly those affecting sleep and mood. The balance between the life-saving protection of the drug and the discomfort of its side effects is a critical question for anyone spending months in a malaria-prone environment.
In a study focused on Indian peacekeepers serving in South Sudan, researchers set out to understand how well this weekly medication worked in a real-world military setting and why some soldiers chose to stop taking it. The team looked back at the records and experiences of 534 soldiers who had spent between six and eighteen months in the country. These individuals had undergone strict medical checks before deployment to ensure they were healthy, and they were all prescribed the same weekly dose of mefloquine. The researchers gathered data by asking the soldiers to fill out a questionnaire when they returned home, recording whether they had taken their medication on time, if they had gotten sick, and what side effects they might have experienced. The goal was to see if sticking to the schedule actually prevented malaria and to identify the specific reasons why some people fell out of the routine.
The results showed a clear and powerful connection between taking the medicine as directed and staying healthy. Among the soldiers who followed the schedule, missing no more than a single dose, only a small fraction contracted malaria. In contrast, those who missed two or more doses in a row were far more likely to get sick. The risk of developing the disease was more than five times higher for those who did not take the medication consistently. This means that for the group that took the drug as prescribed, the medicine prevented the vast majority of malaria cases that would have otherwise occurred. Even though the drug worked well, it was not a perfect shield; a few soldiers who took every dose still got infected, proving that the medication must be paired with other safety measures like mosquito nets and repellents.
Despite the clear benefit, not everyone took the drug every week. About fourteen percent of the soldiers reported that they had missed doses. When the researchers asked why, the answers pointed to a single, dominant fear: the side effects of the medicine. Nearly thirty percent of those who missed doses cited the drug's side effects as their reason, either because they had already felt them or because they were afraid they would. The most common complaints were trouble sleeping and vivid, disturbing dreams. Some soldiers also reported feelings of anxiety, restlessness, or depression. Interestingly, the group that stopped taking the drug was much more likely to report these side effects than the group that kept taking it, suggesting that the fear of feeling unwell was a major barrier to staying on the schedule. Other reasons for missing doses included simply forgetting or believing that mosquito nets alone were enough to keep them safe.
The study highlights a difficult reality for medical teams working in high-stress environments like peacekeeping missions. While the medication is a powerful tool that can reduce the risk of malaria by a large margin, its success depends entirely on the soldier's willingness to keep taking it. The research suggests that the biggest obstacle is not a lack of supplies or a failure to understand the rules, but rather the human reaction to the drug's side effects. To improve future outcomes, the authors suggest that better preparation is needed before soldiers leave home. This includes honest conversations about what side effects to expect, such as sleep disturbances, so that they are not caught off guard. It also means having a plan for those who cannot tolerate the drug, offering them alternative medicines so they do not have to choose between their health and their duty. Ultimately, the study confirms that mefloquine is a highly effective shield when used correctly, but its power is only realized when the people taking it feel safe enough to continue the routine.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.